Camouflage Protein‐Engineered Extracellular Vesicles Alleviate TMJ‐OA by Hijacking Caspase‐1 to Suppress Pyroptosis
Journal of Extracellular Vesicles · 2026
DOI: 10.1002/jev2.70342 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2026. Verfasst von Yufei Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bioactive Materials, School of Life Sciences, Ministry of Education, Nankai University, Tianjin, China. Hauptthemen laut MEDLINE: Pyroptosis, Extracellular Vesicles, Caspase 1, Osteoarthritis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tianjin Research Program of Application Foundation, Tianjin Research Program of Application Foundation and Advanced Technology of China, Tianjin Key Medical Discipline Construction Project.
Abstract (Originalsprache)
Temporomandibular joint osteoarthritis (TMJ‐OA) is highly prevalent with an insidious onset. Severe inflammation and significant degenerative changes are often associated with the condition, and current clinical treatments remain inadequate. In this study, we focus on pyroptosis and engineered the camouflage protein (GSDMD‐C) attached to the membrane surface of small extracellular vesicles (sEVs)–sEV‐p. sEV‐p has two key effects: firstly, the inherent immunomodulatory and nutritional support properties of sEVs promote the recovery of cellular function under pathological conditions; secondly, camouflage protein bind to the activated caspase‐1, reducing the cleavage of endogenous GSDMD. The therapeutic effects of sEV‐p were evaluated through in vitro experiments and treatment of TMJ‐OA models in mice and Bama pigs. We further elucidated the mechanisms by single‐cell RNA sequencing analysis. Results show that sEV‐p alleviates the abnormal activation of inflammatory factors induced by pyroptosis, accompanied by a reduction in the proportion of inflammatory cells and a mitigation of acute inflammatory responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Bioactive Materials, School of Life Sciences, Ministry of Education, Nankai University, Tianjin, China.
- Key Laboratory of Oral Functional Reconstruction, Tianjin, Tianjin, China.
- Department of Occlusion and Temporomandibular Joint Disease, Tianjin Stomatological Hospital, School of Medicine, Nankai University, Tianjin, China.
- Hebei Naco Biotechnology Co. Ltd, Hebei, China.
ORCID-Profile: Shufang Wang
Förderung
- Tianjin Research Program of Application Foundation
- Tianjin Research Program of Application Foundation and Advanced Technology of China
- Tianjin Key Medical Discipline Construction Project
- Jinan Clinical Medical Science and Technology Innovation Plan
Zitieren
APA
Liu, Y., Zhou, J., Wang, Y., Hu, Z., Yin, G., Zhu, M., Huo, J., Zhang, C., Wang, Y., Fu, S., Wan, J., Wang, J., Xu, L., Zhang, Z., & Wang, S. (2026). Camouflage Protein‐Engineered Extracellular Vesicles Alleviate TMJ‐OA by Hijacking Caspase‐1 to Suppress Pyroptosis. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70342
Vancouver
Liu Y, Zhou J, Wang Y, Hu Z, Yin G, Zhu M, et al. Camouflage Protein‐Engineered Extracellular Vesicles Alleviate TMJ‐OA by Hijacking Caspase‐1 to Suppress Pyroptosis. Journal of Extracellular Vesicles. 2026. doi:10.1002/jev2.70342
BibTeX
@article{Liu2026,
author = {Liu, Yufei and Zhou, Jie and Wang, Yukang and Hu, Zhihui and Yin, Guimin and Zhu, Mengsen and Huo, Jianke and Zhang, Chenyang and Wang, Yiming and Fu, Shuang and Wan, Jinpeng and Wang, Jie and Xu, Lanju and Zhang, Zhiling and Wang, Shufang},
title = {Camouflage Protein‐Engineered Extracellular Vesicles Alleviate TMJ‐OA by Hijacking Caspase‐1 to Suppress Pyroptosis},
journal = {Journal of Extracellular Vesicles},
year = {2026},
doi = {10.1002/jev2.70342}
}
EUVIMED